Gaudium IVF and Women Health IPO: Issue Opens For Subscription Today; Check GMP

Gaudium IVF, a prominent fertility services provider based in New Delhi, has launched its Initial Public Offering (IPO) with plans to raise ₹165 crore. The subscription period for this mainboard offering commenced today and will remain open until February 24. The funds raised through the IPO will be utilized for various growth initiatives, including expanding their network of fertility clinics and enhancing service capabilities. As the demand for fertility services continues to rise in India, Gaudium IVF aims to capitalize on this growing market. Investors are keenly observing the issue's Grey Market Premium (GMP), which indicates market sentiment and potential listing gains. The IPO is expected to attract significant interest from both institutional and retail investors looking to invest in the burgeoning healthcare sector, particularly in specialized services like reproductive health. Gaudium IVF has established itself as a leader in the field, making this offering a noteworthy event in the Indian financial landscape as it seeks to broaden its operational footprint and improve accessibility to fertility treatments across the country.